##### CLINICAL TRIALS

# Streamlining clinical trials and enrollment with voice biomarker technology.

Canary Speech coordinates all supply chain stakeholders to streamline clinical trials. Our technology allows non-invasive, cost-effective data collection to track patient outcomes at scale. We make participation more accessible, convenient, and sustainable for patients, clinicians, and sponsors.

## 76%

76% of 200+ polled clinical trial sponsors stated they conducted most or all of their patient monitoring remotely.

## 9 out of 10

9 out of 10 trials require the original timeline to be doubled in order to meet enrollment goals.

## 92.7%

92.7% of oncology patients state it’s important to speak with clinical researchers before joining a trial.

Clinical trials are no longer bound by processing times to collect participant data. Our technology gives research teams access to objective, actionable data immediately. Trial participants provide a 20-second audio sample and our system returns an analysis in less than a minute.

###### The ability to use voice to identify MS would offer a quick, non-invasive screening tool, enabling us to deliver faster care to patients. We’re thrilled to collaborate with Canary Speech and leverage their innovative technology in this pioneering study.

#### Dr. Timothy West

Neurologist with Intermountain Health